ScienceDex / Researcher record
Daniel R. Kuritzkes
- Brigham and Women's Hospital · Internal Medicine (investigator's affiliation)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- Top 5% Funded
- R01 Holder
- Early Career
- Mentor
- Diverse Portfolio
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $7,837,528 | 6 | #524 |
| 2025 | $7,971,760 | 5 | #661 |
| 2026 | $7,589,606 | 4 | #1,420 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected6 records
- FY20255 records
- FY20264 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1872615Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Microbiology & Immunology
FY2024 award records by amount
NIH award records listing Daniel R. Kuritzkes as a PI. Multi-PI records show the full award amount for context.
- 5UM1AI069412-18UM1Contact PIBoston HIV CTUBrigham and Women's Hospital · Internal Medicine (investigator's affiliation)$3.5Maward amount
- 5U01AI179561-02U01Co-investigatorA Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in BotswanaHarvard T.H. Chan School of Public Health · Microbiology & Immunology (NIH department code)$2.1Maward amount
- 5U01AI135940-07U01Co-investigatorA clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in BotswanaHarvard T.H. Chan School of Public Health · Microbiology & Immunology (NIH department code)$951.4Kaward amount
- 5R01AI157854-04R01Co-investigatorHIV-1 dynamics and evolution during trispecific broadly neutralizing antibody therapyBrigham and Women's Hospital · Internal Medicine (investigator's affiliation)$791.8Kaward amount
- 5T32AI007387-35T32Contact PIMultidisciplinary AIDS Training ProgramBrigham and Women's Hospital · Internal Medicine (investigator's affiliation)$449.9Kaward amount
- 1R13AI186262-01R13Contact PIViral Infection and Inflammation Workshop 2024Brigham and Women's Hospital · Internal Medicine (investigator's affiliation)$7Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Daniel R. Kuritzkes as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardBrigham and Women's Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #524
- 2024Entered Top 25% NationallyRanked #524
- 2024Entered Top 10% NationallyRanked #524
- 2024Entered Top 5% NationallyRanked #524
- 2025$10M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Daniel R. Kuritzkes.